Table 1.
lncRNA | Diagnostic efficacy | Reference |
---|---|---|
| ||
MALAT1 | Circulating MALAT1, AUC=0.79 | 21 |
Exosomal MALAT1, AUC=0.703 | 22 | |
GAS5 | Circulating GAS5, AUC=0.832 | 25 |
Combination of GAS5 and CEA, AUC=0.909 | ||
XIST and HIF1A-AS1 | Circulating XIST, AUC=0.834 | 26 |
Circulating HIF1A-AS1, AUC=0.876 | ||
Combination of XIST and HIF1A-AS1, AUC=0.931 | ||
SPRY4-IT1, ANRIL, and NEAT1 | Circulating SPRY4-IT1, AUC=0.603 | 27 |
Circulating ANRIL, AUC=0.798 | ||
Circulating NEAT1, AUC=0.693 | ||
Combination of SPRY4-IT1, ANRIL, and NEAT1; AUC=0.876 | ||
SOX2OT and ANRIL | Circulating SOX2OT, AUC=0.745 | 28 |
Circulating ANRIL, AUC=0.723 | ||
Combination of SOX2OT, ANRIL, CEA, CYFRA21-1, and SCCA; AUC=0.853 |
Abbreviations: AUC, area under the receiver operating characteristic curve; NSCLC, non-small cell lung cancer; CEA, carcinoembryonic antigen.